Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
life sciences
national blog main
new york blog main
3
×
alnylam pharmaceuticals
boston blog main
cancer
clinical trials
fda
national top stories
new york top stories
novartis
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
10x genomics
abbvie
akouos
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astellas pharma
astrazeneca
becton dickinson
biogen
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
cancer immunotherapy
cerovene
What
deal
3
×
company
help
medicines
acquire
acquisitions
adding
agreed
aims
announced
billion
bio
brings
cash
ceo
cholesterol
collabs
compound
covid
daniel
decisions
diagnostic
diagnostics
drug
expand
fda
fold
gilead
gilead’s
introduce
ipo
make
medco
month
nanostring
new
novartis
o’day
physicians
plans
Language
unset
3
×
Current search:
deal
×
unset
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
